Successful High-Dose Ribavirin Treatment of Respiratory Syncytial Virus-Induced Tracheobronchitis and Pneumonia Occuring Pre-Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

被引：0
|
作者：
Gueller, Saskia [1 ]
Duenzinger, Ulrich [1 ]
Wolf, Timo [1 ]
Mousset, Sabine [1 ]
Martin, Hans [1 ]
Serve, Hubert [1 ]
Bug, Gesine [1 ]
机构：
[1] Goethe Univ Frankfurt, Dept Med, Frankfurt, Germany
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：478 / 478
页数：1
相关论文
共 40 条
  • [31] DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation
    Dhakal, B.
    D'Souza, A.
    Pasquini, M.
    Saber, W.
    Fenske, T. S.
    Moss, R. B.
    Drobyski, W. R.
    Hari, P.
    Abidi, M. Z.
    CASE REPORTS IN MEDICINE, 2016, 2016
  • [32] Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes
    Akhmedov, Mobil
    Wais, Verena
    Sala, Elisa
    Neagoie, Adela
    Thanh Mai Nguyen
    Gantner, Andrea
    von Harsdorf, Stephanie
    Kuchenbauer, Florian
    Schubert, Axel
    Michel, Detlef
    Doehner, Hartmut
    Bunjes, Donald
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (04)
  • [33] Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab
    Permpalung, Nitipong
    Mahoney, Monica V.
    McCoy, Christopher
    Atsawarungruangkit, Amporn
    Gold, Howard S.
    Levine, James D.
    Wong, Michael T.
    LaSalvia, Mary T.
    Alonso, Carolyn D.
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 85 - 91
  • [34] Oral Ribavirin for the Treatment of Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections in Hematology Patients and Stem Cell Transplant (SCT) Recipients at a Nci-Designated Cancer Center
    Pasikhova, Yanina
    Hayne, Justin
    Baluch, Aliyah
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S383 - S383
  • [35] The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
    Albert, E.
    Solano, C.
    Gimenez, E.
    Focosi, D.
    Perez, A.
    Macera, L.
    Pinana, J. L.
    Boluda, J. C. H.
    Maggi, F.
    Navarro, D.
    BONE MARROW TRANSPLANTATION, 2018, 53 (02) : 180 - 187
  • [36] The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
    E Albert
    C Solano
    E Giménez
    D Focosi
    A Pérez
    L Macera
    J L Piñana
    J C H Boluda
    F Maggi
    D Navarro
    Bone Marrow Transplantation, 2018, 53 : 180 - 187
  • [37] Outcome of allogeneic hematopoietic stem cell transplant tation after adding high-dose cytarabine to the conventional Cy/TBI conditioning regimen for the treatment of philadelphia-chromosome-positive acute lymphoblastic leukemia
    Yoo, KH
    Kook, H
    Sung, KW
    Jung, HL
    Koo, HH
    Baek, HJ
    Hwang, TJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 87 - 88
  • [38] Successful Treatment of Multifocal Histiocytic Sarcoma Occurring after Renal Transplantation with Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) Followed by Allogeneic Hematopoietic Stem Cell Transplantation
    Tomlin, Julia
    Orosco, Ryan K.
    Boles, Sarah
    Tipps, Ann
    Wang, Huan-You
    Husseman, Jacob
    Wieduwilt, Matthew
    CASE REPORTS IN HEMATOLOGY, 2015, 2015
  • [39] Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes
    Nicolas Stocker
    Myriam Labopin
    Inès Boussen
    Olivier Paccoud
    Agnès Bonnin
    Florent Malard
    Corinne Amiel
    Joël Gozlan
    Giorgia Battipaglia
    Rémy Duléry
    Federica Giannotti
    Annalisa Ruggeri
    Béatrice Gaugler
    Mohamad Mohty
    Eolia Brissot
    Bone Marrow Transplantation, 2020, 55 : 586 - 594
  • [40] Pre-emptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes
    Stocker, Nicolas
    Labopin, Myriam
    Boussen, Ines
    Paccoud, Olivier
    Bonnin, Agnes
    Malard, Florent
    Amiel, Corinne
    Gozlan, Joel
    Battipaglia, Giorgia
    Dulery, Remy
    Giannotti, Federica
    Ruggeri, Annalisa
    Gaugler, Beatrice
    Mohty, Mohamad
    Brissot, Eolia
    BONE MARROW TRANSPLANTATION, 2020, 55 (03) : 586 - 594
1234